High Tower Advisors, LLC Fibrogen Inc Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Fibrogen Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 102,988 shares of FGEN stock, worth $40,165. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,988

Previous 102,988 -0.0%

Holding current value

$40,165

Previous $91,000 54.95%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.89 - $2.36 $7,377 - $19,562	8,289 Added 8.75%	102,988 $91,000
Q1 2024 May 06, 2024	SELL	$0.73 - $2.73 $104,255 - $389,887	-142,816 Reduced 60.13%	94,699 $222,000
Q4 2023 Feb 12, 2024	BUY	$0.38 - $0.91 $54,270 - $129,962	142,816 Added 150.81%	237,515 $211,000
Q3 2023 Nov 08, 2023	SELL	$0.79 - $2.83 $238 - $854	-302 Reduced 0.32%	94,699 $81,000
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $22,357 - $184,877	8,979 Added 10.44%	95,001 $256,000
Q2 2022 Aug 10, 2022	BUY	$7.94 - $12.96 $37,318 - $60,912	4,700 Added 5.78%	86,022 $908,000
Q4 2021 Feb 10, 2022	BUY	$9.93 - $15.39 $4,965 - $7,695	500 Added 0.62%	81,322 $1.15 Million
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $437 - $1,145	-43 Reduced 0.05%	80,822 $826,000
Q2 2021 Aug 06, 2021	BUY	$18.57 - $35.68 $70,621 - $135,691	3,803 Added 4.93%	80,865 $2.15 Million
Q1 2021 May 10, 2021	BUY	$31.0 - $55.72 $183,520 - $329,862	5,920 Added 8.32%	77,062 $2.67 Million
Q4 2020 Feb 10, 2021	BUY	$37.09 - $48.97 $36,756 - $48,529	991 Added 1.41%	71,142 $2.64 Million
Q3 2020 Nov 13, 2020	BUY	$40.47 - $45.5 $242,820 - $273,000	6,000 Added 9.35%	70,151 $2.88 Million
Q2 2020 Aug 10, 2020	BUY	$32.57 - $42.83 $149,105 - $196,075	4,578 Added 7.68%	64,151 $2.6 Million
Q1 2020 May 21, 2020	BUY	$23.3 - $45.96 $412,526 - $813,721	17,705 Added 42.29%	59,573 $2.07 Million
Q4 2019 Feb 14, 2020	SELL	$34.58 - $48.06 $34,476 - $47,915	-997 Reduced 2.33%	41,868 $1.8 Million
Q3 2019 Nov 12, 2019	SELL	$36.98 - $48.45 $6,471 - $8,478	-175 Reduced 0.41%	42,865 $1.58 Million
Q2 2019 Aug 13, 2019	BUY	$35.13 - $55.53 $609,540 - $963,501	17,351 Added 67.54%	43,040 $1.95 Million
Q1 2019 May 15, 2019	SELL	$42.83 - $59.91 $71,783 - $100,409	-1,676 Reduced 6.12%	25,689 $1.4 Million
Q4 2018 Feb 14, 2019	BUY	$37.97 - $60.16 $1.04 Million - $1.65 Million	27,365 New	27,365 $1.27 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $36.6M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Fibrogen Inc Transaction History